Spectrum Pharmaceuticals (NASDAQ:SPPI) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 25 percent increase over losses of $(0.16) per share from the same period last year.
SEC Adopts Rule To Increase Transparency Into Short Selling and Amendment To CAT NMS Plan For Purposes Of Short Sale Data Collection
https://www.sec.gov/news/press-release/2023-221 SEC Adopts Rule to Increase Transparency Into Short Selling and Amendment to CAT NMS Plan for Purposes of Short Sale Data CollectionWashington, D.C.--(Newsfile Corp. -
